Colon Cancer Cells Evade Drug Action by Enhancing Drug Metabolism

The authors used liquid chromatography/mass spectrometry analyses on Drosophila CRC tumor models to identify multiple metabolites in the glucuronidation pathway as upregulated in trametinib-resistant RAS/APC/P53 tumors compared to trametinib-sensitive Ras^G12V single mutant tumours.